Dr Yue Chiu Sun Consultant and Head Division of Cardiology Dept of Medicine & Geriatrics United Christian Hospital 6 Apr 2014.

Slides:



Advertisements
Similar presentations
LQTS Outline Background Identification Therapies Available
Advertisements

APPROACH TO WIDE QRS COMPLEX TACHYCARDIA
Management of the Patient Presenting with Wide Complex Tachycardia
ECG interpretation for beginners Part 4 – Acute coronary syndromes
UNC Emergency Medicine Medical Student Lecture Series
Brugada’s Syndrome and Sudden Cardiac Death
ECG Rhythm Interpretation
Chapter Page, 12-Lead ECG for Acute and Critical Care Providers © 2006 by Pearson Education, Inc. Upper Saddle River, NJ Electrolyte, Drug, and Other ECG.
Ventricular Tachycardia
April 1 st, 2013 Heart Failure Education Series David N. Edwards, M.D. Ph.D. F.A.C.C. Advanced Heart Care, PA The Heart Hospital Baylor Plano.
Atrial and Ventricular Enlargement
DOMENICO CORRADO, MD, PhD University of Padova, Italy
Hypertrophic Cardiomyopathy Guidelines Summary from the: ACC/ESC Clinical Expert Consensus Statement on Hypertrophic Cardiomyopathy Maron BJ, et al. J.
Brugada Syndrome Carly Thompson MD CCFP EM Resident July 31, 2008.
Thursday 4/12/2014 Hassan Alahmadi Medical Resident ( R1)
Overlapping genetic syndromes Ramon Brugada Director, Centre de Genètica Cardiovascular IDIBGI Cardiologist, Hospital Josep Trueta Dean, School of Medicine,
EKG Myocardial infarction and other ischemic states
Syncope AM Report 6/25/10 Nicole Wilde. Syncope  Cause Not Obvious Neurally Mediated (vasovagal) 58% Cardiac Disease (arrhythmias) 23% Neurologic or.
Cardiac Arrhythmia. Cardiac Arrhythmia Definition: The pumping action of the heart is coordinated by an electrical system within the heart tissue.
Primary Myocardial Disease Dr. Raid Jastania. Case.
Jay Green Emergency Medicine Resident, PGY-3 July 24, 2008.
Electrocardiogram Interpretation: A Brief Overview
Dr. Meg-angela Christi M. Amores
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Kate Martin CNE April Kate Martin CNE  Chest pain that prompts a visit to the emergency department,  Post cardiac surgery  Patients at risk for.
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
Amiodarone Use in Cardiac Surgical Resuscitation
Indication and contra-indications for cardiac catheterization
Department faculty and hospital therapy of medical faculty and department internal diseases of medical prophylactic faculty. Cardiac arrhythmia Docent.
F. Propagation of cardiac impulse The Normal Conduction System.
DR. ZAHOOR 1.  A 50 year old man presents to clinic with a complaint of central chest discomfort of 2 weeks’ duration, occurring after walking for more.
Jenny Morrison Morning Report 4/28/2008.  Cardiomyopathy characterized by transient apical and midventricular LV dysfunction in the absence of significant.
Ventriclar Tachycardia
Clinical Teaching Case Anthony Battad MD, FRCPC University of Manitoba.
Long QT and TdP Morning Report Elias Hanna, LSU Cardiology.
Acute Coronary Syndrome What is Acute Coronary Syndrome ? How can I look at an EKG and tell what part of the heart is affected ? What do ICU RNs need to.
Tachyarrhythmia Gaurav Panchal. Arrhythmogenesis Impulse formation –Automaticity – inappropriate Tachy / brady; accelerated Ventricular rate after MI.
Chapter 12 – Miscellaneous Conditions  Artifact  Digitalis Effect  Pericarditis  Early Repolarization  Low Voltage  Hypo- and Hypercalcemia  Hyperkalemia.
Cooling off on Therapeutic Hypothermia: Long QTc during Therapeutic Hypothermia – An Underreported phenomenon Chima-Okereke, Chidinma MD; Cosgriff, JoAnne.
ELECTROCARDIOGRAM (ECG)
ECG PRACTICAL APPROACH Dr. Hossam Hassan Consultant Emergency Medicine.
Differential Diagnosis of ST Segment Elevation
ECGs: Ischemia and Infarction AFAMS Resident Orientation 26 March 2012.
William M. Miles, MD, FHRS University of Florida College of Medicine Gainesville, FL ICD Implantation: Genetic Arrhythmia Syndromes.
The Electrical Management of Cardiac Rhythm Disorders Tachycardia Indications for ICD Implantation.
Epidemiology Incidence is unknown although some have estimated 1-2% of all patients presenting with “ACS” Mean age is and rarely has been reported.
Arrhythmias. Cardiac dysrhythmia Cardiac dysrhythmia (arrhytmia) Abnormal electrical activity in the heart.
1 Nora Goldschlager, M.D. Cardiology – San Francisco General Hospital UCSF Disclosures: None ECG MIMICS OF MYOCARDIAL ISCHEMIA AND INFARCTION.
ECG etc… (Miscellaneous ECGs) Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
 R40: 30 yo man found unconscious, on ambo arrival VT. ROSC after single DC shock  In ED conscious, mildly intoxicated  Normal bloods, CXR, alcohol.
© 2008, American Heart Association. All rights reserved. AHA/ACC/HRS Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying.
UCI Internal Medicine Mini-Lecture
ECG in myocardial ischemia and other pathologic processes Prof. Hanáček
ARRYTHMIAS IN THE YOUNG Dr Mark Earley, Consultant Cardiologist BMI The London Independent Hospital St Bartholomew’s Hospital.
Emergency Medicine Junior Teaching Programme Aberdeen Royal Infirmary Adult Syncope Evaluation in the Emergency Department Jamie Cooper Teaching 4 th March.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prevalence and Characteristics of Early Repolarization.
Victoria L. Vetter, MD, MPH, Youth Heart Watch Medical Director
Cardiomyopathies Pavol Tomašov.
Cardiac causes of cardiac arrest
Disclosures None.
Implantable Defibrillator Therapy Post Cardiac Arrest
ECG PRACTICAL APPROACH
The Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel
Brugada’s Syndrome and Sudden Cardiac Death
HYPERTROPHIC CARDIOMYOPATHY(HCM)
ECG PRACTICAL APPROACH
Syncope in children.
ECG Lecture Scott Ewing, D.O. March 23, 2006.
Intern Case Report Susan Seago 3/6/2015.
Presentation transcript:

Dr Yue Chiu Sun Consultant and Head Division of Cardiology Dept of Medicine & Geriatrics United Christian Hospital 6 Apr 2014

Case 1 Mr. WWK age 51 Non-smoker, non-drinker PMH: psoriasis Mother diagnosed to have HOCM family screening previously recommended

Presentation Played badminton after work -> sudden collapse Bystander CPR started Ambulance crew arrived VF

At AED BP 133/92 P 120 bpm Given amiodarone infusion GCS 3/15 PERL Intubated for ventilatory support Consulted CCU-> admitted for further management

ECG abnormality?

At CCU Bedside Echo Fair echogenicity Overall satisfactory LV systolic function No apparent RWMA noted No LVH noted to suggest HCM or LVOT obstruction No pericardial effusion Seizure given sodium valproate 400 mg q8h iv Urgent CT brain: no SOL / haemorrhage

What’s next step?

Progress Consulted ICU Admitted ICU Therapeutic hypothermia sedation (dormicum, morphine) + muscle relaxant (atracurium) induction with 2.5L of 4°C ice cold saline aimed at body T 32-34°C; maintained with wet blankets continued rectal probe monitoring Inotropic support NG tube feeding started ECG : ST↑V2-3 and T  V2-4 LDH 301 → 288; CK 395 → 932 TnT 33 → 1169 aspirin 160 mg daily PO started

During Hypothermia

Progress ECG : deep T  over V2-6 (probable ACS : Anterior NSTEMI) Echo: - LV anteroseptal & apical hypokinesia; impaired LV function Re-warming with 0.25 °C per hr Reduced inotropic support gradually Extubated the next day -> transferred back to CCU

To CCU Clopidogrel, Simvastatin, Metoprolol were added bedside echo: LVEF 50%, fair LV contraction; RWMA noted (similar to ICU findings) Fully alert, not in heart failure Coronary angiogram and PCI was performed R dominance, LM normal, LAD proximal 80%, mid LAD 70% stenosis, LCx mild disease, RCA normal Stenting to proximal and mid LAD Uneventful recovery and discharged home

Post-PCI

Anterior STEMI: Therapeutic Hypothermia and Primary PCI

Post-Cardiac Arrest Care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care R ecommend that comatose (ie, lack of meaningful response to verbal commands) adult patients with ROSC after out-of- hospital VF cardiac arrest should be cooled to 32°C to 34°C (89.6°F to 93.2°F) for 12 to 24 hours (Class I, LOE B) Induced hypothermia also may be considered for comatose adult patients with ROSC after in-hospital cardiac arrest of any initial rhythm or after out-of-hospital cardiac arrest with an initial rhythm of pulseless electric activity or asystole (Class IIb, LOE B) Circulation. 2010;122:S768-S786

Post–cardiac arrest care algorithm Peberdy M A et al. Circulation. 2010;122:S768-S786 Copyright © American Heart Association, Inc. All rights reserved.

Case 2 Mr WWM age 52 History of idiopathic DCMP (CTCA-> normal coronary arteries) and AF Admitted for post-VT/VF arrest after being found collapse in street (pulseless VT/VF with prolonged resuscitation > 1 hr and repeated defibrillation); intubated for mechanical ventilation

VT after admission

Progress Acute renal and liver failure requiring temporary HD support Progressive improvement and extubated later Echo: poor LV function EF ~20% with global hypokinesia Coronary angiogram: mild CAD only ICD was implanted Transfer to convalescence hospital for rehabilitation, good neurological recovery

Diagnostic Approach to SCD survivor 1. Clinical History eg. known IHD/congenital heart disease or past history of MI, CV risk profile, triggering factors (exercise, stress – eg. ACS, WPW, HCM, AS, CPVT ) 2. Family history of hereditary cardiac arrhythmia or congenital heart disease, FH of SCD 3. Transient and reversible causes 4. Evaluation for structural heart disease 5. Evaluation for those without structural heart disease

Clinical History and Baseline Investigation Transient or reversible causes Evidence of ACS esp. STEMI Drug history: anti-arrhythmic drugs, psychiatric drugs, OTC drugs, herbal medicine, drug abuse Medications esp. those ↑ QTc Electrolyte and acid-base abnormalities: hypokalemia  K, hyperkalemia ↑K,  Ca, acidosis

Investigations for SCD survivor 1. ECG - Myocardial ischemia or infarction (? ST elevation in V1 & aVR) - myocarditis (eg. T wave inversion, ST segment elevation or depression, heart block, ↑QT interval) - high grade AV block - Brugada Syndrome (polymorphic VT/VF) - Long QT or short QT - Wolf-Parkinson-White WPW syndrome esp. preexcited AF - CPVT, Early repolarization syndrome (ERS)

ECG PR: short PR (WPW with preexcitation) Q wave: MI QRS: delta wave, BBB QT  : congenital long QT, acquired QT  : short QT ST  : STEMI, myocarditis, Brugada syndrome ST  : myocardial ischemia, NSTEMI, myocarditis T  : tall T wave in  K, hyperacute phase in AMI T  : myocardial ischemia, NSTEMI, epsilon wave (ARVC) P and QRS relationship: high grade AV block J point elevation

ECG diagnosis? Brugada ECG

Brugada syndrome: polymorphic VT/VF

WPW with preexcited AF

Early repolarization syndrome ERS ERS is defined as an elevation of the J point (the junction between the end of the QRS complex and the beginning of the ST segment) and/or ST segment by at least 0.1 mV from baseline

Early repolarization syndrome ERS ERS can be divided into three subtypes: Type 1 - which is predominantly characterized by an ERP that is detected with lateral precordial leads, is prevalent among healthy male athletes and rarely seen in VF survivors Type 2 - which is predominantly detected through the inferior or inferolateral leads, is associated with a higher level of arrhythmia risk than type 1 ERS Type 3 - which involves ERPs that are observed globally through the inferior, lateral, and right precordial leads, is associated with the highest level of risk for malignant arrhythmias and often associated with VF storms

Early repolarization syndrome ERS early repolarization in the inferior ECG leads has been associated with idiopathic VF and has been termed as ERS ERS has emerged as a marker of risk for idiopathic VF and sudden death. However, the incidental discovery of a J wave on routine screening should not be interpreted as a marker of “high risk” for sudden death Ann Noninvasive Electrocardiol 2014;19(1):15–22

Catecholaminergic Polymorphic VT (CPVT) Affected patients typically present with life-threatening VT or VF occurring during emotional or physical stress, with syncope often being the first manifestation of the disease. Although sporadic cases occur, this is a largely familial disease. The majority of known cases are due to mutations in the cardiac ryanodine receptor, which is the cardiac sarcoplasmic calcium release channel VT morphology may vary continuously, from beat to beat, or may appear as a bidirectional VT

Congenital Long QT syndrome LQTS

Long QT1

Congenital Long QT syndrome GeneSyndromeFrequencyLocus Protein (Functional Effect) KCNQ1 (LQT1)RWS, JLNS40–5511p15.5Kv7.1 ( ↓ ) KCNH2 (LQT2)RWS30–457q35–36Kv11.1 ( ↓ ) SCN5A (LQT3)RWS5–103p21–p24NaV1.5 ( ↑ ) ANKB (LQT4)RWS<1%4q25–q27Ankyrin B ( ↓ ) KCNE1 (LQT5)RWS, JLNS<1%21q22.1MinK ( ↓ ) KCNE2 (LQT6)RWS<1%21q22.1MiRP1 ( ↓ ) KCNJ2 (LQT7)AS<1%17q23Kir2.1 ( ↓ ) CACNA1C (LQT8)TS<1%12p13.3 L-type calcium channel ( ↑ ) CAV3 (LQT9)RWS<1%3p25Caveolin 3 ( ↓ ) SCN4B (LQT10)RWS<1%11q23.3 Sodium channel-β4 ( ↓ ) AKAP9 (LQT11)RWS<1%7q21–q22Yotiao ( ↓ ) SNTA1 (LQT12)RWS<1%20q11.2Syntrophin α1 ( ↓ ) KCNJ5 (LQT13)RWS<1%11q24Kir3.4 ( ↓ )

Short QT syndrome

Genetic basis of SQTS QTc (msec)Locus Gene (cardiac ion channel) SQT 1286 ± 611p15KCNH2 (I Kr ) ↑ SQT 23027q35KCNQ1 (I Ks ) ↑ SQT q23KCNJ2 (I K1 ) ↑ SQT p12CACNB2b (I Ca ) ↓ SQT p13CACNA1C (I Ca ) ↓ SQT 63307q21-22CACNA2D1 (I Ca ) ↓

Investigations for SCD survivor 2. Blood tests eg. RFT, ABG, cardiac biomarkers, Ca, Mg, drug level (digoxin, TCA etc.), toxicology screen

Investigations for SCD survivor 3. Echocardiogram - LV function and EF, RWMA, heart chamber size - significant valvular disease eg. aortic stenosis - cardiomyopathy eg. DCM, HCM/HOCM, ARVC

Investigations for SCD survivor 4. Coronary angiography and cardiac catheterization - r/o significant coronary artery disease, anomalous coronary arteries (? coronary artery course between aorta & pulmonary trunk), congenital heart disease 5. CT scan - aortic dissestion, coronary anomaly, congenital heart disease 6. Cardiac MRI - structural heart disease eg. HCM, ARVC, LV non-compaction

Investigations for SCD survivor 7. EP study (limited role : post-cardiac arrest) - exclude other arrhythmias, ablative therapy (?WPW, VT foci) 8. Genetic testing, family screening and counselling eg. long QT, HCM, Brugada syndrome, CPVT - commercially available genetic testing exists for HCM, DCM, ARVC, LV non-compaction, LQTS, SQTS, CPVT, and BrS

Genetic Testing for Potentially Lethal, Highly Treatable Inherited Cardiomyopathies/Channelopathies in Clinical Practice David J. Tester and Michael J. Ackerman Circulation. 2011;123:

Indications for genetic testing. Provided is a table of possible indications for genetic testing for hypertrophic cardiomyopathy (HCM), long-QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), and Brugada syndrome (BrS). LVH indicates left ventricular hypertrophy; QTc, corrected QT interval; TdP, torsade de pointes; Neg., negative; and SUD, sudden unexplained death. The plus symbol ( ) represents a positive indication for genetic testing; the negative symbol ( ) represents an indicator that does not warrant genetic testing for the specific disorder; and the / symbol represents an indicator that may or may not warrant genetic testing.

Utility of genetic testing. Shown is the current diagnostic, prognostic, and therapeutic utility of genetic testing for hypertrophic cardiomyopathy (HCM), long-QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), and Brugada syndrome (BrS). The plus symbol ( ) indicates the test has utility, the negative symbol ( ) indicates no current measurable utility, and the / symbol indicates the test may have some utility